Navigation Links
Frost & Sullivan Honors Clinical Ink for Developing an eSource Platform that Streamlines Clinical Development
Date:9/3/2014

MOUNTAIN VIEW, Calif., Sept. 3, 2014 /PRNewswire/ -- Based on its recent analysis of the eClinical solutions market, Frost & Sullivan recognizes Clinical Ink with the 2014 North American eClinical Solutions Award for Entrepreneurial Company of the Year. The award recognizes Clinical Ink's innovative SureSource® platform -- the  first purpose-built eSource solution that captures data electronically at the point of care.

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in devising a strong growth strategy and robustly implementing it. The recipient has shown strength in terms of innovation in products and technologies, leadership in customer value, as well as speed in response to market needs.  In short, the award looks at the emerging market players in the industry and recognizes best practices that are positioned to fundamentally impact the clinical development process.

"The intuitive SureSource platform offers the freedom to work without regard to connectivity, while allowing fast and secure electronic transmission of source documents and data," said Jennifer Lazar, Frost & Sullivan Global Program Director, Life Sciences. "Clinical Ink's client and user satisfaction has been extremely positive, with nearly 80 percent of users claiming that SureSource positively affected their clinical trial process and that they are eager to use it again."

Clinical Ink is well-positioned to realize the FDA's vision of eliminating paper in the clinical trial process (FDA's recently released eSource guidance clearly "promotes" and "encourages" capturing data electronically).  The SureSource platform has been used in more than 50 studies worldwide and early adoption metrics show dramatic reductions in critical timelines and the potential to reduce monitoring cost by up to 50 percent. 

Unlike existing electronic data capture (EDC) platforms, SureSource allows site users to immediately capture data during the subject visit, using a tablet equipped with custom-built electronic source (eSource) forms.  Reflecting the clinical workflow of sites, SureSource eSource forms look just like traditional paper source, but incorporate sophisticated data validations and safeguards to clean data at the time it is initially captured.  The clinical data is immediately available for real-time, remote review by sites, sponsors, and CROs – a dramatic improvement from the weeks/months it can take in the traditional EDC model.  

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Clinical Ink

With offices in Winston-Salem, NC and Philadelphia, PA, Clinical Ink is an innovation-driven eSource solutions company committed to delivering technology that makes clinical research easier for sites, sponsors, subjects and regulators.  Developers of SureSource®, the first purpose-built eSource platform that provides cleaner data faster, Clinical Ink is dedicated to eliminating paper documents in clinical research.  Additional information about Clinical Ink is available at www.clinicalink.com or by calling toll-free 800-301-5033.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210.247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

Alicia Maguire
P: 336.464.0696
E: alicia.maguire@clinicalink.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors
2. Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan
3. Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market
4. Frost & Sullivan Applauds Volpara Solutions Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer
5. Frost & Sullivan: Multi-Modality Breast Imaging Systems Spur Innovations in Europe
6. Frost & Sullivan: Healthcare Investor Focus on Malaysia Grows, Bolstered by Government Support and Medical Tourism
7. Frost & Sullivan Recognizes Baxano Surgical as a Leader in MIS Spine Innovation
8. Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry
9. Frost & Sullivan Applauds F Cubed for its Game-Changing MRSA Screener, the NESDEP IU
10. Frost & Sullivan Honors Mobius Imaging for Developing a Mobile 32-Slice CT Scanner, the Airo Mobile Intraoperative CT
11. Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
Breaking Medicine Technology:
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
Breaking Medicine News(10 mins):